UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000043913
Receipt number R000050103
Scientific Title Validation research on body-temperature regulation by test-food intakes
Date of disclosure of the study information 2022/04/15
Last modified on 2022/04/11 13:14:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Validation research on body-temperature regulation by test-food intakes

Acronym

Validation research on body-temperature regulation by test-food intakes

Scientific Title

Validation research on body-temperature regulation by test-food intakes

Scientific Title:Acronym

Validation research on body-temperature regulation by test-food intakes

Region

Japan


Condition

Condition

Healthy male adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To verify some kind of improvement effect in body-temperature regulation by ingesting the test food to the subjects

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Changing rate of core-body temperature (drum temperature)

Key secondary outcomes

1. Body weight-changing rate
2. Plasma volume-changing rate
3. Total protein
4. Albumin
5. Serum sodium
6. Serum osmolality
7. Fractional excretion of sodium
8. Creatinine clearance
9. Free water clearance
10. Voided volume
11. Bloodstream (OMEGAZONE)
12. Heartbeat rate (Polar Unite)
13. Subjective symptoms based on a visual analog scale questionnaire (feebleness, thirst, hotness)


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Freely consumption of the test/placebo food (two bottles a day) to the subject for five days at home.

Interventions/Control_2

On admission, consumption of the test/placebo food (two bottles a day) to the subject at the appointed time.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Male

Key inclusion criteria

(1) Healthy male subjects ranging in age from 20 to 64, at informed consent.
(2) Subjects ranging in BMI from 18.5 to less than 25.0 kg/m2.
(3) Subjects who can give informed consent to participate in this trial, after being provided with an explanation of the protocol detail.

Key exclusion criteria

(1) Subjects who have any difficulty in doing exercises with a bicycle ergometer for approximately 30 min.
(2) Subjects falling into the habit of excessive alcohol intake.
(3) Subjects who have the habit of smoking, at the present time and/or within a year before this trial.
(4) Subjects with extremely irregular life rhythm.
(5) Subjects with previous and/or current medical history of serious diseases in heart, liver, kidney and/or digestive organs.
(6) Subjects being under some kind of continuous medical treatment, and/or planning to have it during this trial.
(7) Subjects having drug and/or food allergy.
(8) Subjects who are now under the other clinical tests with some kind of medicine/food, or took part in those within four weeks before this trial, or will join those after giving informed consent to participate in this trial.
(9) Subjects who donated 400 mL of their whole blood within the last three months before this trial.
(10) Others who have been determined as ineligible for participation, judging from the principal/sub investigator's opinions.

Target sample size

15


Research contact person

Name of lead principal investigator

1st name Kazunori
Middle name
Last name Kato

Organization

Toyo University

Division name

Professor, Director of the center

Zip code

350-0815

Address

2100 Kujirai, Kawagoe, Saitama 350-0815, Japan

TEL

049-239-1397

Email

k-kato@toyo.jp


Public contact

Name of contact person

1st name Makoto
Middle name
Last name Ichinohe

Organization

CPCC Company Limited

Division name

Clinical Planning Department

Zip code

101-0047

Address

4F Sanwa-Uchi-Kanda Building, 3-3-5 Uchi-Kanda, Chiyoda-ku, Tokyo 101-0047, Japan

TEL

03-5297-3112

Homepage URL


Email

cpcc-contact@cpcc.co.jp


Sponsor or person

Institute

CPCC Company Limited

Institute

Department

Personal name



Funding Source

Organization

EZAKI GLICO CO., LTD.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of Chiyoda Paramedical Care Clinic

Address

2F Sanwa-Uchi-Kanda Building, 3-3-5 Uchi-Kanda, Chiyoda-ku, Tokyo 101-0047, Japan

Tel

03-5297-5548

Email

IRB@cpcc.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 04 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 03 Month 23 Day

Date of IRB

2021 Year 03 Month 19 Day

Anticipated trial start date

2021 Year 04 Month 15 Day

Last follow-up date

2021 Year 06 Month 11 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 04 Month 13 Day

Last modified on

2022 Year 04 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000050103


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name